KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Receivables: 2015-2025

Historic Receivables for Medpace Holdings (MEDP) over the last 9 years, with Sep 2025 value amounting to $383.8 million.

  • Medpace Holdings' Receivables rose 20.61% to $383.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 11.09%. This contributed to the annual value of $301.8 million for FY2024, which is 5.95% down from last year.
  • As of Q3 2025, Medpace Holdings' Receivables stood at $383.8 million, which was down 0.05% from $383.9 million recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Receivables registered a high of $383.9 million during Q2 2025, and its lowest value of $188.4 million during Q1 2021.
  • For the 3-year period, Medpace Holdings' Receivables averaged around $322.3 million, with its median value being $310.0 million (2024).
  • As far as peak fluctuations go, Medpace Holdings' Receivables surged by 40.31% in 2022, and later declined by 5.95% in 2024.
  • Medpace Holdings' Receivables (Quarterly) stood at $222.5 million in 2021, then surged by 32.03% to $293.8 million in 2022, then climbed by 9.21% to $320.9 million in 2023, then fell by 5.95% to $301.8 million in 2024, then rose by 20.61% to $383.8 million in 2025.
  • Its Receivables stands at $383.8 million for Q3 2025, versus $383.9 million for Q2 2025 and $304.5 million for Q1 2025.